A randomized, double-blind, placebo-controlled trial of tegaserod in female patients suffering from irritable bowel syndrome with constipation.
about
Placebos without deception: a randomized controlled trial in irritable bowel syndromeTegaserod for the treatment of irritable bowel syndrome and chronic constipationTegaserod for the treatment of irritable bowel syndromeComponents of placebo effect: randomised controlled trial in patients with irritable bowel syndromeA controlled crossover study of the selective serotonin reuptake inhibitor citalopram in irritable bowel syndromeFood elimination based on IgG antibodies in irritable bowel syndrome: a randomised controlled trialAbdominal bloating: pathophysiology and treatmentThe effects of withdrawing tegaserod treatment in comparison with continuous treatment in irritable bowel syndrome patients with abdominal pain/discomfort, bloating and constipation: a clinical study.Review article: the safety profile of tegaserod.Nucleotide supplementation: a randomised double-blind placebo controlled trial of IntestAidIB in people with Irritable Bowel Syndrome [ISRCTN67764449].Tegaserod for constipation-predominant irritable bowel syndrome.Review article: the treatment of functional abdominal bloating and distension.Pharmacologic and complementary and alternative medicine therapies for irritable bowel syndrome.Comparison of long-term effects of cognitive-behavioral therapy versus mindfulness-based therapy on reduction of symptoms among patients suffering from irritable bowel syndromeThe effects of cognitive behavioral therapy and drug therapy on quality of life and symptoms of patients with irritable bowel syndrome.Linaclotide: A new drug for the treatment of chronic constipation and irritable bowel syndrome with constipationA randomized, double-blind, placebo-controlled trial assessing the efficacy and safety of tegaserod in patients from China with chronic constipation.The effect of tegaserod on symptoms and quality of life in korean women with irritable bowel syndrome with constipationComments on tegaserod trial on irritable bowel syndrome.Low-dose nocturnal tegaserod or erythromycin delays symptom recurrence after treatment of irritable bowel syndrome based on presumed bacterial overgrowth.Constipation-predominant irritable bowel syndrome: a review of current and emerging drug therapies.Recent advances in pharmacological treatment of irritable bowel syndrome.Randomised clinical trials: linaclotide phase 3 studies in IBS-C - a prespecified further analysis based on European Medicines Agency-specified endpoints.Symptomatic efficacy of beidellitic montmorillonite in irritable bowel syndrome: a randomized, controlled trial.The treatment of irritable bowel syndromeThe placebo effect in irritable bowel syndrome trials: a meta-analysis.Promotility medications--now and in the future.Antibiotics for irritable bowel syndrome: rationale and current evidence.Enteric P2X receptors as potential targets for drug treatment of the irritable bowel syndromeNovel therapies in the treatment of irritable bowel syndrome.Pharmacological treatment of irritable bowel syndrome: a critical assessment.An Asia-Pacific, double blind, placebo controlled, randomised study to evaluate the efficacy, safety, and tolerability of tegaserod in patients with irritable bowel syndrome.Tegaserod and IBS: a perfect match?Pharmacology of serotonin: what a clinician should know.A randomised controlled trial assessing the efficacy and safety of repeated tegaserod therapy in women with irritable bowel syndrome with constipationSystematic review: incidence of abdominal/pelvic surgery amongst patients using tegaserod in randomized controlled trials.Antibiotics for the treatment of irritable bowel syndromePathophysiology, evaluation, and treatment of bloating: hope, hype, or hot air?Tegaserod-induced myocardial infarction: case report and hypothesis.Gastrointestinal pain in functional bowel disorders: sensory neurons as novel drug targets.
P2860
Q21091076-9FE5D0DB-038E-41BA-8DEC-12B9E863A20CQ24242922-3664D515-ED16-421B-8203-596152EF122FQ24247426-7ABD5FE9-69DA-4ECA-979B-7B793A93227DQ24647883-3904E31E-2765-4E77-837A-60FF23D020D3Q24680181-0386F0A7-4FBB-4874-82F1-E6FD9C365170Q24685836-F3FDE6CC-9C41-4927-B4C1-114350ACB43FQ26851622-508C928E-8A97-47D5-96FF-752DBF2F14C7Q33431815-3268C49E-AA16-492E-883A-CF4D49E545B0Q33432438-4A4CD6BA-1646-4453-BB53-7DE7D4890999Q33435380-852BEC29-D9EA-4337-8BCD-4F05D2E200D2Q33436477-A07DB2F9-7187-4C24-9276-232DB94DF738Q33450132-B4300530-C373-44D7-8CAB-7C131112AA12Q33451900-3AB481BC-3CDA-4354-98BB-524C9E94A142Q33596819-EAB94018-E6FC-486A-B3AD-DE30019B3977Q33635500-46FBF0E8-72B2-426A-98FC-F04B8B5F1513Q33695487-1974DB6B-007A-40CC-B408-DED517700BCEQ33788020-51AB2157-5084-4E78-804D-E46DD4432C1DQ33890463-3DF80224-9A46-4EC1-974C-E1F816E866F8Q33890572-0AB0CB89-21F7-4B59-A884-4C23D3E84799Q33916182-4952B2C9-C1AC-414D-8A10-CB42CA9B5376Q33958710-FA2C6838-B707-4660-B9D2-322B37247ECBQ33958853-AADEB9DA-DBBA-48B2-A40C-C9A0619D0D37Q34309302-4C0C8A10-B8AA-4F3D-984C-6DE720007CD2Q34394157-25366AAF-C4EA-4741-ABC5-37439A5CA4EFQ34409009-445C8843-D06D-4478-AEA0-4B8C770219C2Q34421382-BD3F3B8D-A534-407A-9D68-5BBF7BFC390AQ34548916-00900C10-FDC1-4AFB-B7A5-C3BD74312BD8Q34642080-15CBB177-259A-4662-AF15-9AE364DA98DBQ35047062-EB2850DE-F2E6-4E5B-BFAE-80257BCB15CEQ35094684-3DC73AEA-321C-4DE8-A4DA-9FECE3CAD379Q35585701-E76093F4-C2ED-48B6-AA16-F5184947EA5FQ35595584-8CFBF43E-7A5B-42F0-A520-1B7B27A4B6E3Q35595588-E1416B6E-1779-4F79-AFB8-A1C3276B61CDQ35596862-E9F69FB8-1EA2-47BB-8C71-BDFCEEC3B9B1Q35597981-13F825BA-F606-49DB-9FDD-17C9109D4EC2Q35675791-27CA153F-D98F-4F77-83BF-CB34D87E4B53Q35691133-68964AD5-A9CC-4F37-BA72-55EB4A18F6FCQ35691226-A9B6E25F-04C8-4EE6-9616-B1DFD43D924FQ35751537-06744516-4633-48F5-86C8-BEDF88ABA8C9Q35753361-50CEBF00-E2CA-4CB3-94A7-79C39B3D7C20
P2860
A randomized, double-blind, placebo-controlled trial of tegaserod in female patients suffering from irritable bowel syndrome with constipation.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
A randomized, double-blind, pl ...... el syndrome with constipation.
@en
A randomized, double-blind, pl ...... el syndrome with constipation.
@nl
type
label
A randomized, double-blind, pl ...... el syndrome with constipation.
@en
A randomized, double-blind, pl ...... el syndrome with constipation.
@nl
prefLabel
A randomized, double-blind, pl ...... el syndrome with constipation.
@en
A randomized, double-blind, pl ...... el syndrome with constipation.
@nl
P2093
P2860
P1476
A randomized, double-blind, pl ...... el syndrome with constipation.
@en
P2093
Bliesath H
Lefkowitz M
P2860
P304
P356
10.1046/J.1365-2036.2002.01372.X
P407
P577
2002-11-01T00:00:00Z